$EYEN
Eyenovia Inc

2019 Q1 Form 10-K Financial Statement

#000114420419016350 Filed on March 27, 2019

View on sec.gov

Income Statement

Concept 2019 Q1 2018 2017 Q4
Revenue $0.00 $0.00 $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $1.940M $6.140M $470.0K
YoY Change 44.78% 365.15% 161.11%
% of Gross Profit
Research & Development $4.009M $11.12M $1.690M
YoY Change 91.44% 191.33% 72.45%
% of Gross Profit
Depreciation & Amortization $2.553K $19.13K $20.00K
YoY Change -52.06% -24.88%
% of Gross Profit
Operating Expenses $5.952M $17.26M $2.160M
YoY Change 73.43% 236.23% 86.21%
Operating Profit -$5.952M -$17.26M
YoY Change 73.43% 236.23%
Interest Expense $19.28K $3.335K $0.00
YoY Change 801.97% 40.13%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income -$5.930M -$17.25M -$2.160M
YoY Change 72.89% 236.26% 86.21%
Income Tax $0.00 $0.00
% Of Pretax Income
Net Earnings -$5.932M -$17.25M -$2.160M
YoY Change 72.98% 236.32% 86.21%
Net Earnings / Revenue
Basic Earnings Per Share
Diluted Earnings Per Share -$497.5K -$1.820M -$217.3K
COMMON SHARES
Basic Shares Outstanding 12.02M
Diluted Shares Outstanding

Balance Sheet

Concept 2019 Q1 2018 2017 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $14.32M $19.73M $5.250M
YoY Change -48.12% 275.81%
Cash & Equivalents $14.32M $5.250M
Short-Term Investments
Other Short-Term Assets $490.0K $130.0K $40.00K
YoY Change 36.11% 225.0%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $14.88M $19.86M $5.287M
YoY Change -46.8% 275.43% 55.97%
LONG-TERM ASSETS
Property, Plant & Equipment $34.19K $40.00K $27.96K
YoY Change 51.03% 33.33% -35.27%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $120.0K $120.0K $330.0K
YoY Change -63.64%
Total Long-Term Assets $152.0K $160.0K $356.7K
YoY Change 571.46% -54.29% 725.75%
TOTAL ASSETS
Total Short-Term Assets $14.88M $19.86M $5.287M
Total Long-Term Assets $152.0K $160.0K $356.7K
Total Assets $15.03M $20.02M $5.643M
YoY Change -46.3% 254.96% 64.39%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $2.061M $1.510M $246.4K
YoY Change 275.32% 504.0% -18.42%
Accrued Expenses $450.0K $1.570M $300.0K
YoY Change -16.67% 423.33%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $2.525M $3.100M $552.6K
YoY Change 124.76% 463.64% 30.42%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $40.00K $40.00K $0.00
YoY Change
Total Long-Term Liabilities $40.00K $40.00K $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $2.525M $3.100M $552.6K
Total Long-Term Liabilities $40.00K $40.00K $0.00
Total Liabilities $2.568M $3.140M $552.6K
YoY Change 129.3% 470.91%
SHAREHOLDERS EQUITY
Retained Earnings -$42.45M -$19.26M
YoY Change 87.07% 36.3%
Common Stock $1.202K $257.00
YoY Change 20.93% 13.22%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $12.46M $16.88M $5.091M
YoY Change
Total Liabilities & Shareholders Equity $15.03M $20.02M $5.643M
YoY Change -46.3% 254.96% 64.39%

Cashflow Statement

Concept 2019 Q1 2018 2017 Q4
OPERATING ACTIVITIES
Net Income -$5.932M -$17.25M -$2.160M
YoY Change 72.98% 236.32% 86.21%
Depreciation, Depletion And Amortization $2.553K $19.13K $20.00K
YoY Change -52.06% -24.88%
Cash From Operating Activities -$5.897M -$13.11M -$1.990M
YoY Change 146.63% 177.13% 113.98%
INVESTING ACTIVITIES
Capital Expenditures $27.91K -$10.00K
YoY Change 172.69% -75.0%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities -$27.91K -$10.00K
YoY Change 172.69% -75.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $0.00 $0.00
YoY Change -100.0%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 483.9K 27.62M -160.0K
YoY Change -98.04% 318.22% -260.0%
NET CHANGE
Cash From Operating Activities -5.897M -13.11M -1.990M
Cash From Investing Activities -27.91K -10.00K
Cash From Financing Activities 483.9K 27.62M -160.0K
Net Change In Cash -5.413M 14.48M -2.160M
YoY Change -124.22% 677.49% 148.28%
FREE CASH FLOW
Cash From Operating Activities -$5.897M -$13.11M -$1.990M
Capital Expenditures $27.91K -$10.00K
Free Cash Flow -$13.14M -$1.980M
YoY Change 177.12% 122.47%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2018Q4 us-gaap Cash
Cash
19728200
CY2017Q4 us-gaap Cash
Cash
5249511
CY2018Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
132756
CY2017Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
37149
CY2018Q4 us-gaap Assets Current
AssetsCurrent
19860956
CY2017Q4 us-gaap Assets Current
AssetsCurrent
5286660
CY2018Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
36738
CY2017Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
27960
CY2018Q4 us-gaap Deferred Finance Costs Noncurrent Net
DeferredFinanceCostsNoncurrentNet
0
CY2017Q4 us-gaap Deferred Finance Costs Noncurrent Net
DeferredFinanceCostsNoncurrentNet
328700
CY2018Q4 us-gaap Assets
Assets
20015494
CY2017Q4 us-gaap Assets
Assets
5643320
CY2018Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
1509524
CY2017Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
246384
CY2018Q4 eyen Accrued Expenses And Other Liabilities Current
AccruedExpensesAndOtherLiabilitiesCurrent
677213
CY2017Q4 eyen Accrued Expenses And Other Liabilities Current
AccruedExpensesAndOtherLiabilitiesCurrent
306263
CY2018Q4 us-gaap Liabilities Current
LiabilitiesCurrent
3098841
CY2017Q4 us-gaap Liabilities Current
LiabilitiesCurrent
552647
CY2018Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2017Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2018Q4 us-gaap Security Deposit
SecurityDeposit
117800
CY2017Q4 us-gaap Security Deposit
SecurityDeposit
0
CY2018Q4 us-gaap Deferred Rent Credit Noncurrent
DeferredRentCreditNoncurrent
41584
CY2017Q4 us-gaap Deferred Rent Credit Noncurrent
DeferredRentCreditNoncurrent
0
CY2018Q4 us-gaap Liabilities
Liabilities
3140425
CY2017Q4 us-gaap Liabilities
Liabilities
552647
CY2018Q4 us-gaap Common Stock Value
CommonStockValue
1147
CY2017Q4 us-gaap Common Stock Value
CommonStockValue
257
CY2018Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
53388216
CY2017Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
24351138
CY2018Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-36514294
CY2017Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-19261186
CY2018Q4 us-gaap Stockholders Equity
StockholdersEquity
16875069
CY2017Q4 us-gaap Stockholders Equity
StockholdersEquity
5090673
CY2018Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
20015494
CY2017Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
5643320
CY2018 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
11119096
CY2017 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
3816732
CY2018 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
6137347
CY2017 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1315635
CY2018 us-gaap Operating Expenses
OperatingExpenses
17256443
CY2017 us-gaap Operating Expenses
OperatingExpenses
5132367
CY2018 us-gaap Operating Income Loss
OperatingIncomeLoss
-17256443
CY2017 us-gaap Operating Income Loss
OperatingIncomeLoss
-5132367
CY2018 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
3335
CY2017 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
2380
CY2018 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-1.82
CY2018 us-gaap Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
503950
CY2017 us-gaap Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
51560
CY2018 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-13111138
CY2017 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-4731110
CY2018 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
27907
CY2017 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
10234
CY2017 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-2.19
CY2018 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
9476706
CY2017 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
2344712
CY2018 us-gaap Net Income Loss
NetIncomeLoss
-17253108
CY2017 us-gaap Net Income Loss
NetIncomeLoss
-5129987
CY2018 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
19129
CY2017 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
25466
CY2018 us-gaap Share Based Compensation
ShareBasedCompensation
1615470
CY2017 us-gaap Share Based Compensation
ShareBasedCompensation
412312
CY2018 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
95607
CY2017 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
34814
CY2018 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
1263140
CY2017 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-55647
CY2018 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-27907
CY2018 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
2241033
CY2017 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
6386532
CY2018Q4 eyen Prepaid Rent And Security Deposit
PrepaidRentAndSecurityDeposit
75729
CY2017Q4 eyen Prepaid Rent And Security Deposit
PrepaidRentAndSecurityDeposit
0
CY2018Q4 us-gaap Prepaid Insurance
PrepaidInsurance
39465
CY2017Q4 us-gaap Prepaid Insurance
PrepaidInsurance
384
CY2018Q4 eyen Prepaid Patent Expense
PrepaidPatentExpense
10562
CY2017Q4 eyen Prepaid Patent Expense
PrepaidPatentExpense
7833
CY2018Q4 eyen Prepaid Research And Development Expenses
PrepaidResearchAndDevelopmentExpenses
0
CY2017 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-10234
CY2018 us-gaap Increase Decrease In Security Deposits
IncreaseDecreaseInSecurityDeposits
-117800
CY2017 us-gaap Increase Decrease In Security Deposits
IncreaseDecreaseInSecurityDeposits
0
CY2018 eyen Increase Decrease In Deferred Rent
IncreaseDecreaseInDeferredRent
41584
CY2017 eyen Increase Decrease In Deferred Rent
IncreaseDecreaseInDeferredRent
0
CY2018 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
14478689
CY2017 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
1862223
CY2017Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
5249511
CY2016Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
3387288
CY2018Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
19728200
CY2018Q1 us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
24500000
CY2018Q4 us-gaap Cash Uninsured Amount
CashUninsuredAmount
19478200
CY2017Q4 us-gaap Cash Uninsured Amount
CashUninsuredAmount
4999511
CY2017Q4 eyen Prepaid Research And Development Expenses
PrepaidResearchAndDevelopmentExpenses
28932
CY2018Q4 eyen Accrued Research And Development Expenses Current
AccruedResearchAndDevelopmentExpensesCurrent
375204
CY2017Q4 eyen Accrued Research And Development Expenses Current
AccruedResearchAndDevelopmentExpensesCurrent
120455
CY2018Q4 eyen Accrued Legal Expenses Current
AccruedLegalExpensesCurrent
168650
CY2017Q4 eyen Accrued Legal Expenses Current
AccruedLegalExpensesCurrent
0
CY2018Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
111728
CY2017Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
41831
CY2018Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
12165
CY2017Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
1134
CY2018Q4 eyen Accrued Expenses And Other Liabilities Currents
AccruedExpensesAndOtherLiabilitiesCurrents
677213
CY2017Q4 eyen Accrued Expenses And Other Liabilities Currents
AccruedExpensesAndOtherLiabilitiesCurrents
306263
CY2018Q4 eyen Accrued Offering Costs
AccruedOfferingCosts
0
CY2017Q4 eyen Accrued Offering Costs
AccruedOfferingCosts
133000
CY2018Q4 eyen Credit Card Payable
CreditCardPayable
9466
CY2017Q4 eyen Credit Card Payable
CreditCardPayable
9843
CY2018Q3 us-gaap Lease Expiration Date1
LeaseExpirationDate1
2023-09-30
CY2018Q3 us-gaap Net Rentable Area
NetRentableArea
3800
CY2018Q3 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
1236000
CY2018Q3 us-gaap Security Deposit
SecurityDeposit
118000
CY2018Q4 us-gaap Operating Leases Future Minimum Payments Due Current
OperatingLeasesFutureMinimumPaymentsDueCurrent
238300
CY2018Q4 us-gaap Operating Leases Future Minimum Payments Due In Two Years
OperatingLeasesFutureMinimumPaymentsDueInTwoYears
244853
CY2018Q4 us-gaap Operating Leases Future Minimum Payments Due In Three Years
OperatingLeasesFutureMinimumPaymentsDueInThreeYears
251586
CY2018Q4 us-gaap Operating Leases Future Minimum Payments Due In Four Years
OperatingLeasesFutureMinimumPaymentsDueInFourYears
258505
CY2018Q4 us-gaap Operating Leases Future Minimum Payments Due In Five Years
OperatingLeasesFutureMinimumPaymentsDueInFiveYears
198157
CY2018Q4 us-gaap Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
1191401
CY2018 us-gaap Loss Contingency Damages Sought Value
LossContingencyDamagesSoughtValue
1100000
CY2018Q4 us-gaap Loss Contingency Damages Sought Value
LossContingencyDamagesSoughtValue
600000
CY2018Q4 us-gaap Malpractice Loss Contingency Insurance Recoveries
MalpracticeLossContingencyInsuranceRecoveries
10000000
CY2018Q4 us-gaap Loss Contingency Accrual Payments
LossContingencyAccrualPayments
150000
CY2018Q4 us-gaap Malpractice Loss Contingency Claims Incurred In Period
MalpracticeLossContingencyClaimsIncurredInPeriod
450000
CY2016Q3 us-gaap Payments For Rent
PaymentsForRent
3000
CY2018Q1 us-gaap Payments For Rent
PaymentsForRent
4000
CY2018Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2018Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
90000000
CY2017Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2017Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
90000000
CY2018Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
11468996
CY2017Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
2566530
CY2018Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
11468996
CY2017Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
2566530
CY2018 us-gaap Conversion Of Stock Amount Issued1
ConversionOfStockAmountIssued1
470
CY2017 us-gaap Conversion Of Stock Amount Issued1
ConversionOfStockAmountIssued1
30
CY2018 eyen Exercise Of Warrants On A Cashless Basis
ExerciseOfWarrantsOnACashlessBasis
6
CY2018 us-gaap Lease And Rental Expense
LeaseAndRentalExpense
32000
CY2017 us-gaap Lease And Rental Expense
LeaseAndRentalExpense
36000
CY2018Q4 eyen Minority Interest Ownership Percentage In Company
MinorityInterestOwnershipPercentageInCompany
0.05
CY2018Q1 us-gaap Convertible Preferred Stock Shares Issued Upon Conversion
ConvertiblePreferredStockSharesIssuedUponConversion
4702116
CY2018 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P2Y2M12D
CY2018Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
175668
CY2018Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Period1
ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
P36M
CY2018Q2 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
8.72
CY2018Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Grant Date Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValue
1412700
CY2018 eyen Sharebased Compensation Arrangement By Sharebased Payment Award Options Grants In Period Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantsInPeriodGrantDateFairValue
2237800
CY2018 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
6.39
CY2017 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
1.77
CY2018Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2018Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
6000000
CY2017Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2017 eyen Exercise Of Warrants On A Cashless Basis
ExerciseOfWarrantsOnACashlessBasis
0
CY2018 eyen Accrual Of Deferred Offering Cost
AccrualOfDeferredOfferingCost
0
CY2017 eyen Accrual Of Deferred Offering Cost
AccrualOfDeferredOfferingCost
133000
CY2018 eyen Payment Of Accrued Issuance Costs
PaymentOfAccruedIssuanceCosts
-133000
CY2017 eyen Payment Of Accrued Issuance Costs
PaymentOfAccruedIssuanceCosts
0
CY2018 dei Entity Incorporation State Country Name
EntityIncorporationStateCountryName
Florida
CY2018 dei Entity Incorporation Date Of Incorporation
EntityIncorporationDateOfIncorporation
2014-03-12
CY2018 eyen Reclassification To Additional Paid In Capital For Ipo Issuance Costs
ReclassificationToAdditionalPaidInCapitalForIPOIssuanceCosts
-195700
CY2017 eyen Reclassification To Additional Paid In Capital For Ipo Issuance Costs
ReclassificationToAdditionalPaidInCapitalForIPOIssuanceCosts
0
CY2018 eyen Percentage Reduction In Preservative
PercentageReductionInPreservative
0.75
CY2018 us-gaap Use Of Estimates
UseOfEstimates
<div style="font-family: 'times new roman', 'serif';font-size: 10pt;margin-bottom: 0;margin-top: 0;text-align: justify;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="text-decoration:underline;display:inline;">Use of Estimates</div></div></div><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, serif; font-size: 10pt; color: rgb(0, 0, 0); background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="font-family: 'times new roman', 'serif';font-size: 10pt;margin-bottom: 0;margin-top: 0;text-align: justify;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">Preparation of financial statements in conformity with accounting principles generally accepted in the United States of America (&#8220;U.S. GAAP&#8221;) requires management to make estimates, judgments and assumptions that affect the amounts reported in the financial statements and the amounts disclosed in the related notes to the financial statements. The Company bases its estimates and judgments on historical experience and on various other assumptions that it believes are reasonable under the circumstances. The amounts of assets and liabilities reported in the Company&#8217;s balance sheets and the amounts of expenses reported for each of the periods presented are affected by estimates and assumptions, which are used for, but not limited to, fair value calculations for equity securities, establishment of valuation allowances for deferred tax assets, stock-based compensation, the recoverability and useful lives of long-lived assets and the recovery of deferred costs. Certain of the Company&#8217;s estimates could be affected by external conditions, including those unique to the Company and general economic conditions. It is reasonably possible that actual results could differ from those estimates.</div></div><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, serif; font-size: 10pt; color: rgb(0, 0, 0); background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="font-family: 'times new roman', 'serif';font-size: 10pt;margin-bottom: 0;margin-top: 0;text-align: justify;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">See Note 2 - Summary of Significant Accounting Policies&#8201;&#8212;&#8201;Stock-Based Compensation for additional discussion of the use of estimates in estimating the fair value of the Company&#8217;s common stock.</div></div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>
CY2018Q4 us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
2800000
CY2018Q4 eyen Prepaid Conference Expenses
PrepaidConferenceExpenses
7000
CY2017Q4 eyen Prepaid Conference Expenses
PrepaidConferenceExpenses
0
CY2018 eyen Income Tax Expense Benefit Before Adjustments For Change In Valuation Allowance
IncomeTaxExpenseBenefitBeforeAdjustmentsForChangeInValuationAllowance
3563960
CY2018Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
102886
CY2017Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
74979
CY2018 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
0
CY2017 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
0
CY2018 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
3516722
CY2017 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
235473
CY2017 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
0
CY2018 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
47238
CY2017 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
80301
CY2017 eyen Income Tax Expense Benefit Before Adjustments For Change In Valuation Allowance
IncomeTaxExpenseBenefitBeforeAdjustmentsForChangeInValuationAllowance
315774
CY2018 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
3563960
CY2017 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
315774
CY2018 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
CY2017 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
CY2018 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.210
CY2017 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.340
CY2018 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.003
CY2017 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.040
CY2018 us-gaap Effective Income Tax Rate Reconciliation Tax Credits Research
EffectiveIncomeTaxRateReconciliationTaxCreditsResearch
0.028
CY2017 us-gaap Effective Income Tax Rate Reconciliation Tax Credits Research
EffectiveIncomeTaxRateReconciliationTaxCreditsResearch
0.063
CY2018 us-gaap Effective Income Tax Rate Reconciliation Prior Year Income Taxes
EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes
0.026
CY2017 us-gaap Effective Income Tax Rate Reconciliation Prior Year Income Taxes
EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes
0.081
CY2018 us-gaap Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate
EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate
0.000
CY2017 us-gaap Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate
EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate
-0.300
CY2018 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
0.207
CY2017 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
0.062
CY2018 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.000
CY2017 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.000
CY2018Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
5453854
CY2017Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
2588641
CY2018Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
616207
CY2017Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
347977
CY2018Q4 us-gaap Deferred Tax Assets In Process Research And Development
DeferredTaxAssetsInProcessResearchAndDevelopment
1008443
CY2017Q4 us-gaap Deferred Tax Assets In Process Research And Development
DeferredTaxAssetsInProcessResearchAndDevelopment
526134
CY2018Q4 us-gaap Deferred Tax Assets Property Plant And Equipment
DeferredTaxAssetsPropertyPlantAndEquipment
2486
CY2017Q4 us-gaap Deferred Tax Assets Property Plant And Equipment
DeferredTaxAssetsPropertyPlantAndEquipment
0
CY2018Q4 us-gaap Deferred Tax Assets Goodwill And Intangible Assets
DeferredTaxAssetsGoodwillAndIntangibleAssets
310230
CY2017Q4 us-gaap Deferred Tax Assets Goodwill And Intangible Assets
DeferredTaxAssetsGoodwillAndIntangibleAssets
364508
CY2018Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
7391220
CY2017Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
3827260
CY2018Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
7391220
CY2017Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
3827260
CY2018Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
0
CY2017Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
0
CY2018 us-gaap Tax Credit Carryforward Limitations On Use
TaxCreditCarryforwardLimitationsOnUse
In accordance with Section 382 of the Internal Revenue Code, the usage of the Company&#8217;s net operating loss carryforwards could become subject to annual limitations if there are greater than 50% ownership changes.
CY2017 us-gaap Income Tax Reconciliation Change In Enacted Tax Rate
IncomeTaxReconciliationChangeInEnactedTaxRate
1500000
CY2017 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
1500000
CY2018 us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
-0.008
CY2017 us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
0.000
CY2017Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Period1
ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
P36M
CY2017Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
173900
CY2018 us-gaap Officers Compensation
OfficersCompensation
165000
CY2018 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
0.0269
CY2018 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
0.0324
CY2017 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
0.0195
CY2017 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
0.0239
CY2017 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
1.3
CY2018 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.00000
CY2017 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.00000
CY2018Q4 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Outstanding Options
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions
2220868
CY2018Q4 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Exercisable Options
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions
1269295
CY2018 us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Remaining Contractual Term2
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2
P7Y1M6D
CY2018Q1 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
2730000
CY2018Q1 us-gaap Shares Issued Price Per Share
SharesIssuedPricePerShare
10.00
CY2018Q1 eyen Gross Proceeds Of Stock Value Issued During Period
GrossProceedsOfStockValueIssuedDuringPeriod
27300000
CY2018Q1 eyen Net Proceeds From Issuance Of Common Stock
NetProceedsFromIssuanceOfCommonStock
24500000
CY2018Q1 us-gaap Payment Of Financing And Stock Issuance Costs
PaymentOfFinancingAndStockIssuanceCosts
2800000
CY2018Q4 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
3730911
CY2017Q3 us-gaap Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
61875
CY2017Q3 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
6.98
CY2018Q4 us-gaap Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
61875
CY2018Q4 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
0.04
CY2018Q4 us-gaap Supplemental Unemployment Benefits Salary Continuation
SupplementalUnemploymentBenefitsSalaryContinuation
1677000
CY2018 us-gaap Severance Costs1
SeveranceCosts1
419000
CY2018Q1 us-gaap Stockholders Equity Reverse Stock Split
StockholdersEquityReverseStockSplit
1-for-3.75
CY2018 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Description
ShareBasedCompensationArrangementByShareBasedPaymentAwardDescription
vest over three years from the date of grant with one-third vesting on the one-year anniversary of the date of grant and the balance vesting monthly over the remaining 24 months
CY2017Q3 eyen Preferred Stock Prorata Allotment Pecentage
PreferredStockProrataAllotmentPecentage
0.75
CY2017Q3 us-gaap Proceeds From Issuance Of Warrants
ProceedsFromIssuanceOfWarrants
431574
CY2017Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
897747
CY2017Q3 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
1.95
CY2017Q3 eyen Sharebased Compensation Arrangement By Sharebased Payment Award Options Grants In Period Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantsInPeriodGrantDateFairValue
1585700
CY2018 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
25089000
CY2017 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
0
CY2018 us-gaap Payments For Repurchase Of Initial Public Offering
PaymentsForRepurchaseOfInitialPublicOffering
345497
CY2017 us-gaap Payments For Repurchase Of Initial Public Offering
PaymentsForRepurchaseOfInitialPublicOffering
195700
CY2018 eyen Proceeds From Sale Of Common Stock In Ipo2
ProceedsFromSaleOfCommonStockInIPO2
3084330
CY2017 eyen Proceeds From Sale Of Common Stock In Ipo2
ProceedsFromSaleOfCommonStockInIPO2
0
CY2018 eyen Payments Of Follow On Repurchase Of Initial Public Offering
PaymentsOfFollowOnRepurchaseOfInitialPublicOffering
266581
CY2017 eyen Payments Of Follow On Repurchase Of Initial Public Offering
PaymentsOfFollowOnRepurchaseOfInitialPublicOffering
0
CY2018 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
56482
CY2017 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
0
CY2018 us-gaap Proceeds From Issuance Of Warrants
ProceedsFromIssuanceOfWarrants
0
CY2017 us-gaap Proceeds From Issuance Of Warrants
ProceedsFromIssuanceOfWarrants
431574
CY2018 us-gaap Proceeds From Issuance Of Convertible Preferred Stock
ProceedsFromIssuanceOfConvertiblePreferredStock
0
CY2017 us-gaap Proceeds From Issuance Of Convertible Preferred Stock
ProceedsFromIssuanceOfConvertiblePreferredStock
6409651
CY2018 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
0
CY2017 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
41958
CY2018 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
27617734
CY2017 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
6603567
CY2017Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
6000000
CY2016Q4 us-gaap Stockholders Equity
StockholdersEquity
3009081
CY2017 us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
431574
CY2017 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
6367693
CY2017 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
0
CY2017 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
412312
CY2018 eyen Stock Issued During Period Value Conversion Of Convertible Securities Upon Initial Public Offering
StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesUponInitialPublicOffering
0
CY2018 eyen Stock Issued During Period Value New Issues One
StockIssuedDuringPeriodValueNewIssuesOne
24547803
CY2018 eyen Stock Issued During Period Value New Issues Two
StockIssuedDuringPeriodValueNewIssuesTwo
2817749
CY2018 eyen Stock Issued During Period Value Exercises Of Warrants
StockIssuedDuringPeriodValueExercisesOfWarrants
0
CY2018 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
56482
CY2018 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1615470
CY2018Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
66148
CY2017Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
47019
CY2018 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2018
CY2018Q4 us-gaap Workers Compensation Liability Current
WorkersCompensationLiabilityCurrent
912104
CY2017Q4 us-gaap Workers Compensation Liability Current
WorkersCompensationLiabilityCurrent
0
CY2018 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
912104
CY2018Q4 us-gaap Accrued Bonuses Current
AccruedBonusesCurrent
694490
CY2017Q4 us-gaap Accrued Bonuses Current
AccruedBonusesCurrent
0
CY2018Q4 us-gaap Accrued Salaries Current
AccruedSalariesCurrent
217614
CY2017Q4 us-gaap Accrued Salaries Current
AccruedSalariesCurrent
0
CY2018Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
912104
CY2017Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
0
CY2018 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
0
CY2018 dei Document Type
DocumentType
10-K
CY2018 dei Amendment Flag
AmendmentFlag
false
CY2018 dei Document Period End Date
DocumentPeriodEndDate
2018-12-31
CY2018 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2018 dei Entity Registrant Name
EntityRegistrantName
EYENOVIA, INC.
CY2018 dei Entity Central Index Key
EntityCentralIndexKey
0001682639
CY2018 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2018 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2018 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2018 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2018 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2018Q2 dei Entity Public Float
EntityPublicFloat
35204910
CY2018 dei Trading Symbol
TradingSymbol
EYEN
CY2019Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
12019148
CY2018 dei Entity Shell Company
EntityShellCompany
false
CY2018 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
CY2018 dei Entity Ex Transition Period
EntityExTransitionPeriod
false
CY2018 dei Entity Small Business
EntitySmallBusiness
true
CY2018Q4 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
25600000
CY2018Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards Not Subject To Expiration
DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration
14800000
CY2018Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards Subject To Expiration
DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration
10800000
CY2018 eyen Operating Loss Carry Forwards Expiration Term
OperatingLossCarryForwardsExpirationTerm
2034 to 2038

Files In Submission

Name View Source Status
0001144204-19-016350-index-headers.html Edgar Link pending
0001144204-19-016350-index.html Edgar Link pending
0001144204-19-016350.txt Edgar Link pending
0001144204-19-016350-xbrl.zip Edgar Link pending
eyen-20181231.xml Edgar Link completed
eyen-20181231.xsd Edgar Link pending
eyen-20181231_cal.xml Edgar Link unprocessable
eyen-20181231_def.xml Edgar Link unprocessable
eyen-20181231_lab.xml Edgar Link unprocessable
eyen-20181231_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
tv516651_10k.htm Edgar Link pending
tv516651_ex23-1.htm Edgar Link pending
tv516651_ex31-1.htm Edgar Link pending
tv516651_ex31-2.htm Edgar Link pending
tv516651_ex32-1.htm Edgar Link pending
tv516651_ex32-2.htm Edgar Link pending
tv516651_img1.jpg Edgar Link pending
tv516651_img10.jpg Edgar Link pending
tv516651_img11.jpg Edgar Link pending
tv516651_img12.jpg Edgar Link pending
tv516651_img13.jpg Edgar Link pending
tv516651_img14.jpg Edgar Link pending
tv516651_img15.jpg Edgar Link pending
tv516651_img16.jpg Edgar Link pending
tv516651_img17.jpg Edgar Link pending
tv516651_img18.jpg Edgar Link pending
tv516651_img19.jpg Edgar Link pending
tv516651_img2.jpg Edgar Link pending
tv516651_img20.jpg Edgar Link pending
tv516651_img3.jpg Edgar Link pending
tv516651_img4.jpg Edgar Link pending
tv516651_img5.jpg Edgar Link pending
tv516651_img6.jpg Edgar Link pending
tv516651_img7.jpg Edgar Link pending
tv516651_img8.jpg Edgar Link pending
tv516651_img9.jpg Edgar Link pending